Reckling W Carlton 4
4 · SI-BONE, Inc. · Filed Jan 17, 2020
Insider Transaction Report
Form 4
SI-BONE, Inc.SIBN
Reckling W Carlton
CMO and VP, Medical Affairs
Transactions
- Exercise/Conversion
Common Stock
2020-01-15$3.96/sh+5,000$19,800→ 49,170 total - Sale
Common Stock
[F1][F2][F3]2020-01-15$21.22/sh−5,000$106,082→ 44,170 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2020-01-15−5,000→ 20,554 totalExercise: $3.96Exp: 2023-03-18→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
- [F2]The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.57, inclusive.
- [F3]Includes 40,080 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
- [F4]The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for W. Carlton Reckling|2020-01-17